| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872563 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 7 Pages |
Abstract
Conclusions: Neoadjuvant chemoradiation with oral tegafur is feasible, well tolerated, and active, with the additional advantage of offering the convenience of oral chemotherapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Juan A. M.D., Ph.D., Felipe A. M.D., Ph.D., Javier M.D., Ph.D., Dolores M.D., Marina M.D., Miguel A. M.D., Esperanza M.D., Javier M.D., Rafael M.D.,